Healthcare Economist September 13, 2024
Jason Shafrin

A paper by Qato et al. (2024) quantifies the degree of of pharmacy benefit manager (PBM) market concentration.

Across all payer types, the PBM market was highly concentrated, with an HHI [Herfindahl Hirschman Index (HHI)] of 1972…the HHI was lowest in commercial insurance (1940), with 90 PBM participants, and highest in Medicare Part D (2399), with 21 PBM participants.

Three PBMs dominate in most all markets. In fact, these three large PBMs (CVS Caremark, Optum Rx, and Express Scripts) account for 73.6% of retail prescriptions filled. This does vary...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma, Pharma / Biotech
Robust Evidence Synthesis To Support Transparent Medicare Drug Price Negotiation
What you should know about ‘breakthrough’ HIV drug
EVERSANA partners Oracle on pharmacovigilance platform
New drug approach could underpin future weight loss therapies, study indicates
Pharma Pulse 10/10/24: Empowering Patients in a Complex Healthcare System, Patients Prefer Sub-Q to IV & more

Share This Article